States Push FDA To Hone Compounding Oversight Plan
State officials expressed skepticism Wednesday about the U.S. Food and Drug Administration's plan to split oversight of compounding pharmacies following a deadly meningitis outbreak, saying different types of compounding should be...To view the full article, register now.
Already a subscriber? Click here to view full article